COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Provided By PR Newswire
Last update: Nov 27, 2024
-Promising results obtained from the pre-clinical study with CollPlant's commercial sized rhCollagen-based regenerative breast implants, demonstrating significant implant vascularization and rapid ingrowth of native tissue
Read more at prnewswire.com11.19
-0.33 (-2.86%)
NASDAQ:CLGN (2/21/2025, 8:09:58 PM)
3.47
-0.01 (-0.22%)
Find more stocks in the Stock Screener
SSYS Latest News and Analysis
20 days ago - ChartmillTraders are paying attention to the gapping stocks in Monday's session.Let's delve into the US markets on Monday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
